Microvascular Research 2015-03-01

Arachidonic acid induces brain endothelial cell apoptosis via p38-MAPK and intracellular calcium signaling.

Justin Evans, YooSeung Ko, Wilmer Mata, Muhammad Saquib, Joel Eldridge, Aaron Cohen-Gadol, H Anne Leaver, Shukun Wang, Maria Teresa Rizzo

Index: Microvasc. Res. 98 , 145-58, (2015)

Full Text: HTML

Abstract

Arachidonic acid (AA), a bioactive fatty acid whose levels increase during neuroinflammation, contributes to cerebral vascular damage and dysfunction. However, the mode of injury and underlying signaling mechanisms remain unknown. Challenge of primary human brain endothelial cells (HBECs) with AA activated a stress response resulting in caspase-3 activation, poly(ADP-ribose) polymerase cleavage, and disruption of monolayer integrity. AA also induced loss of mitochondrial membrane potential and cytochrome c release consistent with activation of intrinsic apoptosis. HBEC stimulation with AA resulted in sustained p38-MAPK activation and subsequent phosphorylation of mitogen-activated protein kinase activated protein-2 (MAPKAP-2) kinase and heat shock protein-27 (Hsp27). Conversely, other unsaturated and saturated fatty acids had no effect. Pharmacological and RNA interference-mediated p38α or p38β suppression abrogated AA signaling to caspase-3 and Hsp27, suggesting involvement of both p38 isoforms in AA-induced HBEC apoptosis. Hsp27 silencing also blocked caspase-3 activation. AA stimulated intracellular calcium release, which was attenuated by inositol 1,4,5-trisphosphate (IP3) receptor antagonists. Blockade of intracellular calcium release decreased caspase-3 activation, but had no effect on AA-induced p38-MAPK activation. However, inhibition of p38-MAPK or blockade of intracellular calcium mobilization abrogated AA-induced cytochrome c release. AA-induced caspase-3 activation was abrogated by pharmacological inhibition of lipooxygenases. These findings support a previously unrecognized signaling cooperation between p38-MAPK/MAPKAP-2/Hsp27 and intracellular calcium release in AA-induced HBEC apoptosis and suggest its relevance to neurological disorders associated with vascular inflammation. Copyright © 2014 Elsevier Inc. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
stearic acid Structure stearic acid
CAS:57-11-4
5,8,11,14-Icosatetraynoic acid Structure 5,8,11,14-Icosatetraynoic acid
CAS:1191-85-1
Nordihydroguaiaretic acid Structure Nordihydroguaiaretic acid
CAS:500-38-9
Palmitic acid Structure Palmitic acid
CAS:57-10-3
Linoleic acid Structure Linoleic acid
CAS:60-33-3
Staurosporine Structure Staurosporine
CAS:62996-74-1
oleic acid Structure oleic acid
CAS:112-80-1
Myristic acid Structure Myristic acid
CAS:544-63-8
2-Aminoethyl Diphenylborinate Structure 2-Aminoethyl Diphenylborinate
CAS:524-95-8